Dr. David M. Boruta II, MD

Dr. Boruta practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Boruta's NPI, 1699729236, was assigned on May 19, 2006. Dr. Boruta graduated from University Of Michigan Medical School in 1996. Dr. Boruta holds Texas license S3358.

Dr. Boruta's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Boruta's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boruta practices. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Boruta's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Boruta is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Boruta's licenses on file in 13 states: Texas, Arizona, Tennessee, Washington, Alabama, Georgia, Louisiana, Mississippi, Oklahoma, Massachusetts, New Hampshire, Wisconsin and North Carolina.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Boruta treats.

CMS data shows 128 Medicare services from Dr. Boruta across 4 procedure codes in 2024, all of them office visits, for 88 Medicare patients. Medicare paid $8,904 for them. Every service was in an office.

CMS counts 88 Medicare patients who saw Dr. Boruta in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boruta's median patient age at 69, with 100% women.

In 2024, Dr. Boruta wrote 38 Medicare Part D claims for 18 patients. 37% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Boruta for performance year 2024, reported as part of a group. Dr. Boruta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Boruta as offering telehealth. CMS counts 13 procedures of removal of the uterus by Dr. Boruta, more than 87% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 70 papers to Dr. Boruta, published from 2009 to 2024. 2013 was the busiest year, with 7. The most frequent topics are Ovarian Neoplasms, Laparoscopy and Endometrial Neoplasms. Dr. Boruta has published most often in Gynecol Oncol. Dr. Boruta's most frequent co-authors are John Orland Schorge, MD, Annekathryn Goodman, MD and Whitfield Board Growdon, MD.

CMS Open Payments shows 25 general payments to Dr. Boruta from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. CooperSurgical, Inc. paid the most, $2,338.

Dmand AI lists 13 awards for Dr. Boruta, most recently Resident Teaching Award in 2018.

Dr. Boruta graduated from University Of Michigan Medical School in 1996. Dr. Boruta is a member of AOA, AAGL, American College of Obstetricians and Gynecologists, New England Association of Gynecologic Oncologists and Society of Gynecologic Oncology.

Dr. Boruta is in network with 6 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. POS plans come from the most carriers, 4. Check the plan with the practice before a visit.